Cable Viewer

Currently released so far... 12900 / 251,287

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07 2011/05/08 2011/05/09 2011/05/10 2011/05/11 2011/05/12 2011/05/13 2011/05/14 2011/05/15 2011/05/16 2011/05/17 2011/05/18 2011/05/19 2011/05/20 2011/05/21 2011/05/22 2011/05/23 2011/05/24

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 94 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/05 1985/06
1986/05
1987/06
1988/01 1988/03 1988/07
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/03 1992/06 1992/09 1992/12
1993/01 1993/10
1994/12
1996/07 1996/11
1997/06 1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11 2002/12
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown Consulate Fukuoka
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata Consulate Karachi
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
AE ASEC AS AR AMGT AFIN AORC AU AG AF APER ABLD ADCO ABUD AM AID AJ AEMR AMED AL ASUP AN AIT ACOA ANET ASIG AA AGMT AINF AFFAIRS ADANA AY AADP ARF ACS AGR AMCHAMS AECL AUC APEC APECO AFGHANISTAN ACAO ASEAN ADM AGAO AND ADPM ATRN ALOW AROC APCS AORG AO AODE ACABQ AX AMEX AZ ARM AQ ATFN AMBASSADOR ACBAQ AFSI AFSN AC ASEX AER AVERY AGRICULTURE ASCH AFU AMG ATPDEA ASECKFRDCVISKIRFPHUMSMIGEG AORL
BR BO BA BM BL BH BK BEXP BILAT BTIO BF BU BD BY BE BG BB BBSR BT BRUSSELS BP BX BC BIDEN BMGT BWC BN BTIU
CA CS CO CD CR CPAS CDG CI CDC CBW CU CVIS CE CONS CH CMGT CASC CY CW CG CJAN CIDA CODEL CWC CIA CBSA CEUDA CFED CLINTON CAC CL CACS CIC CHR CAPC CM CT CTR COM CROS CN COPUOS CV CF CARSON CONDOLEEZZA CICTE CYPRUS COUNTER COUNTRY CBE CKGR CVR COUNTERTERRORISM CITEL CLEARANCE COE CARICOM CB CSW CITT CACM CDB CJUS CTM CAN CLMT CBC CNARC CIS
DEAX DHS DAO DCM DJ DA DR DEA DE DOD DOMESTIC DO DEFENSE DK DPRK DEPT DISENGAGEMENT DOE DTRA DS
EFIN ECON ETRD EAID EC EU EUN EINV EG ETTC EIND ELAB EAGR ECIN EINT ENRG EFIS ELTN EAIR EPET EZ ET ENERG ECPS EWWT EI ETRN EINVECONSENVCSJA EEPET EUNCH ER ES EN EMIN ESENV ENNP ENGR ETRDEINVECINPGOVCS ENVI ECINECONCS ELN EFTA ELECTIONS ENVR EXTERNAL ENIV ESA EPA ETRO ETRDECONWTOCS EUR ECUN EXIM EK EUREM ECONOMY EUMEM ERNG EFINECONCS EAIDS ECA ETRC EINVEFIN ETC EAP EINN ECONOMIC EXBS ENGY ECONOMICS EIAR EINDETRD ECONEFIN EURN EDU ETRDEINVTINTCS ECIP EFIM EREL EINVETC ECONCS ETRA EAIG EUC ERD
FI FR FJ FBI FO FDA FAO FTA FOR FTAA FMLN FISO FAS FAC FREEDOM FM FOREIGN FARC FINANCE FINR FOI
GV GM GH GT GG GR GA GTIP GY GOI GZ GAERC GE GCC GOV GERARD GANGS GLOBAL GTMO GL GF GAZA
HEBRON HSTC HA HUMOR HU HO HR HK HILLARY HYMPSK HI HURI HUMAN
IQ IR IS IN IA IC IZ ICRC ID IDA IT IO IAEA ICJ ICAO IV IBRD IMF IAHRC IWC ILO ISLAMISTS IGAD ILC ITU ITF INRA INRO ICTY INRB ITALY IBET IL INTELSAT ISRAELI IMO IDP ICTR ITRA IRC IRAQI IEFIN IPR IIP INMARSAT ITPGOV ITALIAN INTERNAL IRS INTERPOL IEA INR ISRAEL IZPREL IRAJ IF ITPHUM IACI INDO
JA JO JP JUS JM JAMES JOHN JOHNNIE JOSEPH
KPAO KMDR KCOR KNNP KJUS KCRM KDEM KVPR KTFN KPRP KTIP KSCA KSUM KTEX KIDE KIRF KV KTIA KN KG KFRD KWMN KUNR KISL KU KGHG KPKO KOMS KPAL KIPR KMCA KOMC KRVC KSEP KAWC KOLY KWBG KACT KFLO KHIV KZ KGIC KBCT KDRG KBTR KCFE KE KHLS KMPI KAWK KPWR KIRC KRAD KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KFLU KPLS KRIM KSTH KDDG KPRV KICC KS KSAF KBIO KREC KCGC KCIP KTDB KWAC KPAI KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KFSC KSTC KMFO KID KNAR KMIG KVRP KNEI KGIT KNSD KHDP KSAC KWMM KR KCOM KAID KENV KVIR KHSA KO KCRS KPOA KTER KFIN KSPR KTBT KX KCMR KMOC KCRCM KBTS KSEO KOCI KNUP KPAONZ KNUC KNNPMNUC KERG KSCI KTLA KCSY KTRD KMRS KNPP KJUST KRCM KCFC KCHG KREL KFTFN KLIG KDEMAF KGCC KICA KHUM KSEC KPIN KESS KDEV KPIR KWWMN KOM KWNM KRFD KRGY KIFR KWMNCS KPAK
LE LY LH LU LI LO LG LA LOG LTTE LAB LT LABOR
MARR MOPS MUCN MCAP MNUC MEPP MTCRE MASS MO MIL MX MAS MEDIA MAR MI MQADHAFI MPOS MTCR MK MG MA MY MU ML MPS MW MD MARAD MC MR MT MTRE MASC MRCRE MAPP MZ MP MOPPS MTS MLS MILI MEPN MEPI MEETINGS MERCOSUR MCC MIK MAPS MV MILITARY MDC MASSMNUC
NI NZ NL NO NPT NATO NS NU NP NPA NSFO NDP NT NW NASA NSG NE NORAD NAFTA NG NATIONAL NSSP NV NSF NK NA NEW NPG NR NGO NIPP NZUS NH NC NRR NAR NATOPREL NSC
OIIP OPRC OTRA OEXC OREP OSCE OVIP OPAD OBSP OECD OFFICIALS OAS OPDC ODIP OPCW OES OFDP OPIC OCS OIC OHUM OSCI OVP ODC OIE OTR OMIG OSAC OFDA ON OCII
PREL PINR PGOV PARM PE PTER PHUM PO PINS PREF PK PM POL PBTS PNAT PHSA PAS PA PL PGIV PHUMPREL POGOV PAK PEL PROP PP PINL PBT PTBS PG PINF PRL PALESTINIAN PSEPC POSTS PAHO PHUMPGOV PGOC PNR PREFA PMIL POLITICS POLICY PROV PBIO PREO PAO PDOV PGOF POV PCI PRAM PSI POLITICAL PAIGH PJUS PARMS PROG PTERE PRGOV PORG PS PKFK PSOE PEPR PPA PINT PMAR PRELP PNG PFOR PUNE PGOVLO PHUMBA POLINT PGOVE PHALANAGE PARTY PDEM PECON PY PLN PHUH PF PHUS PU PARTIES PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA
QA
RU RS REGION REACTION REPORT RO RW RCMP RSO RP RM ROOD RFE RICE ROBERT RSP RF RELATIONS RIGHTS RIGHTSPOLMIL RUPREL
SENV SY SNAR SCUL SP SF SW SOCI SU SMIG SO SA SR SZ SI SC SEVN SN STEINBERG SK SH SNARCS SPCE SARS SNARN SG SL SYRIA SIPRS SAARC SNARIZ SWE SYR SEN SCRS SAN ST SIPDIS SSA SPCVIS SOFA SENVKGHG SANC SHI SHUM
TU TSPA TBIO TS TRGY TINT TPHY TN TW TH TZ TSPL TP TBID TI TF TD TT TNGD TL TC THPY TIP TX TV TK TERRORISM TO TRSY TURKEY TFIN TAGS TR
UK UNSC UNGA UNESCO UNHRC UP UN USTR US UNDC UY UNICEF UNDP UNMIK UNAUS UNCHC UNCSD USOAS UNFCYP UG UNIDROIT UNO UV UNHCR UNEP USEU UZ UNCND USUN UNCHR USNC USPS USAID UE UNVIE UAE UNODC UNCHS UNFICYP UNDESCO UNC UNPUOS
VZ VT VE VI VM VTPREL VN VTIZ VTEG VAT VC
WHTI WTRO WTRQ WBG WHO WHA WFP WS WTO WB WI WMD WIPO WZ WWARD WITH WEU WMO WA
XS XH XR XL XG XA XM XK XD XF XI XB XV XW XQ XE XTAG XU XT XX XY XZ XC
YM YI YE YMCS
ZI ZK ZR ZU ZO ZP ZF ZEALAND ZL ZOELLICK ZB ZJ ZN ZA ZANU

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 08HELSINKI311, FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08HELSINKI311.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
08HELSINKI311 | 2008-07-09 09:35 | 2011-04-24 00:00 | UNCLASSIFIED | Embassy Helsinki

`

    VZCZCXYZ0002
    RR RUEHWEB

    DE RUEHHE #0311/01 1910935
    ZNR UUUUU ZZH
    R 090935Z JUL 08
    FM AMEMBASSY HELSINKI
    TO RUEHC/SECSTATE WASHDC 4415
    RUCPDOC/DEPT OF COMMERCE WASHDC
    INFO RUCNMEU/EU INTEREST COLLECTIVE
    RUEHNY/AMEMBASSY OSLO 4744

` `

    UNCLAS HELSINKI 000311

    SIPDIS

    E.O. 12958: N/A
    TAGS: ETRD FI PREL
    SUBJECT: FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

    REFERENCE PRICING SYSTEM

    ¶1. Summary:  In a disappointing move and despite Embassy and
    industry efforts, the Finnish cabinet voted unanimously June
    25 to approve a reference pricing scheme for pharmaceuticals,
    a provision of which undermines the value of patent
    protection for medicines created and manufactured by U.S. and
    other pharmaceutical companies. Parliament is expected to
    approve the proposal at the end of the summer.  Despite the
    fact that the Ministry of Economy and Employment, the
    Ministry of Foreign Affairs and the Chancellor of Justice
    initially opposed the proposal and Prime Minister Vanhanen
    was equivocal, in the end all acquiesced and supported the
    Minister of Social Affairs and Health and the short-term
    attraction of an estimated 50 million euros annually in
    savings.  Embassy will engage key parliamentary figures in
    the next month to urge that the government develop a revised
    proposal that achieves their stated objective of containing
    health care costs but that will maintain the level of
    intellectual property protection that pharmaceutical
    companies have previously enjoyed in Finland and continue to
    enjoy elsewhere in the European Union.  If the proposal
    passes as written, post will consult with local U.S. industry
    and Washington to determine if a Special 301 listing is
    appropriate in the 2009 cycle.  End Summary.

    ----------
    Background
    ----------

    ¶2.  Product patents have been granted in Finland only since
    ¶1995.  As such, nearly all products on the Finnish market are
    still protected only by analoguous process patents.  Prior to
    2006, when Finland enacted the fix it is now proposing to
    withdraw, the level of protection for innovative medicines in
    Finland was among the lowest in the EU.  At that time,
    industry faced three major hurdles that taken together formed
    a perfect storm:  weak patent protection, liberal market
    authorization and mandatory generic substitution.

    --------------------------------------------- -------
    Finland Does the Right Thing But Then Changes Course
    --------------------------------------------- -------

    ¶3.  After much Industry and Embassy lobbying, in 2006, the
    Finnish government established criteria in Section 57(c) of
    its Medicines Act that excluded pharmaceutical products from
    generic reimbursement if they were protected by an analogus
    process patent in Finland and enjoyed valid patent protection
    in at least five other countries in the European Union.
    57(c) was the result of long negotiations and was seen by
    industry as a fair and equitable solution.  Indeed, it was
    used as an example for other countries, notably Norway, of
    the ideal legislative remedy.  Trouble started in the summer
    of 2007 when the Finnish Pharmaceutical Pricing Board (PPB)
    began cancelling the reimbursement status of some innovative
    drugs, claiming the PPB was bound only by the Health
    Insurance Act, not the the Medicines Act that contained the
    exclusion criteria. At first, Industry and Econoff believed
    this was an isolated action by an overzealous PPB chief,
    especially because when we raised it with the newly-installed
    Health Minister, she freely admitted she did not know what we
    were talking about.  Clearly she eventually got up to speed,
    because before long her ministry was overtly supporting the
    complete withdrawal of the 57(c) arrangement instead of
    supporting similar exclusion criteria for the Health
    Insurance Act as industry was proposing.

    ------------------------
    USG and Industry Efforts
    ------------------------

    ¶4. Beginning late last year, Econoff and Commercial Officer
    began working closely with the U.S. pharmaceutical company
    representatives here in Finland as well as with the local
    trade association Pharma Industry Finland (PIF) and its
    director, former Finance Minister Suvi-Anne Siimes to devise
    a strategy to head off the cancellation of 57(c).  Since
    January 2008 the Embassy has raised this at the highest level
    of Finnish government, including with the Prime Minister but
    also with virtually every other minister in the entire
    government.  Our strategy, carefully coordinated with
    industry and Washington, has focused on underscoring that
    Finland's knowledge-based economy has attracted much r&d
    investment, including health-related project funds from the
    USG.  A small IPR deficiency would undermine Finland's
    deserved reputation for innovation, a blow that was surely
    not worth the short-term gains from savings.  Industry
    reinforced this message during the visit of Alex Azar, Eli
    Lilly's Senior VP for Corporate Affairs (and a former Deputy
    Secretary of HHS) and through intensive lobbying by PIF and
    Siimes.  Siimes has also reached out to the German, French

    and Swiss Embassies whose companies also stand to suffer
    under the new arrangement.  USTR Ambassador Schwab and
    Secretary Gutierrez have written their Finnish counterparts
    on this issue and it has been raised with the Finnish Embassy
    in Washington and during the visits of high-level Finnish
    government officials.

    ----------
    Next Steps
    ----------

    ¶5.  With the cabinet's approval of the reference pricing
    scheme and the subsequent removal of the protection
    innovative products enjoyed under Section 57(c), there are
    few steps left.  Nonetheless, Embassy has a small window
    until the end of the summer when parliament will reconvene
    and consider the proposal.  Given that the MPs' party
    representatives in the cabinet have already approved the
    proposal, however, chances for success are slim.  However, we
    remain committed to raising this with parliamentary leaders
    in an attempt to encourage the development of a revised
    proposal.  If that fails, we will examine whether this
    unfortunate set of events merits Finland's inclusion on the
    Special 301 list.

    BUTLER

`